FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs

FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs

Submitted by admin on January 23, 2025 - 11:44am
Source: 
BioSpace
News Tags: 
Teva Pharmaceutical
black box
MS
multiple sclerosis
FDA
anaphylaxis
Headline: 
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
snippet: 

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since December 1996 and six patient deaths.

Do Not Allow Advertisers to Use My Personal information